AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY
Authors: FRIEDRICH MG DECHEND R BARKOWSKI A JUNGNICKEL K BACHER P WELZEL D DIETZ R GULBA DC
Citation: Mg. Friedrich et al., PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 981-981
STUDIES ON THE THROMBOGENIC EFFECTS OF RECOMBINANT TISSUE FACTOR - IN-VIVO VERSUS EX-VIVO FINDINGS
Authors: CALLAS DD BACHER P FAREED J
Citation: Dd. Callas et al., STUDIES ON THE THROMBOGENIC EFFECTS OF RECOMBINANT TISSUE FACTOR - IN-VIVO VERSUS EX-VIVO FINDINGS, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 166-176
EVALUATION OF HEMOSTATIC AND FIBRINOLYTIC ALTERATIONS ASSOCIATED WITHDAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN FOR A 12-WEEK PERIOD
Authors: LOJEWSKI B BACHER P IQBAL O WALENGA JM HOPPENSTEADT D LEYA F FAREED J
Citation: B. Lojewski et al., EVALUATION OF HEMOSTATIC AND FIBRINOLYTIC ALTERATIONS ASSOCIATED WITHDAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN FOR A 12-WEEK PERIOD, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 228-239
OUTPATIENT USE OF LOW-MOLECULAR-WEIGHT HEPARINS FOR POSTSURGICAL AND MEDICAL PROPHYLAXIS OF VENOUS THROMBOSIS
Authors: BICK R CLARIZIO R FAREED J BACHER P WOLF H
Citation: R. Bick et al., OUTPATIENT USE OF LOW-MOLECULAR-WEIGHT HEPARINS FOR POSTSURGICAL AND MEDICAL PROPHYLAXIS OF VENOUS THROMBOSIS, Blood, 86(10), 1995, pp. 3642-3642
FIBRINOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SITE-DIRECTED INHIBITORS OF THROMBIN
Authors: CALLAS D BACHER P IQBAL O HOPPENSTEADT D FAREED J
Citation: D. Callas et al., FIBRINOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SITE-DIRECTED INHIBITORS OF THROMBIN, Thrombosis research, 74(3), 1994, pp. 193-205
THROMBOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SYNTHETIC AND RECOMBINANT ANTITHROMBIN AGENTS
Authors: FAREED J CALLAS DD BAJUSZ S BACHER P IQBAL O HOPPENSTEADT D WALENGA JM PIFARRE R
Citation: J. Fareed et al., THROMBOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SYNTHETIC AND RECOMBINANT ANTITHROMBIN AGENTS, Blood, 84(10), 1994, pp. 10000071-10000071
INTERNATIONAL REACTOR DEVELOPMENT - SHOWN WITH THE EPR
Authors: CARLE R BACHER P
Citation: R. Carle et P. Bacher, INTERNATIONAL REACTOR DEVELOPMENT - SHOWN WITH THE EPR, Atw. Atomwirtschaft, Atomtechnik, 38(8-9), 1993, pp. 602-604
HEMOSTATIC PROFILE OF A 3 MONTHS DAILY SUBCUTANEOUS TREATMENT WITH LMW HEPARIN
Authors: BACHER P LOJEWSKI B IQBAL O WALENGA JM LEYA F WOLF H WELZEL D FAREED J
Citation: P. Bacher et al., HEMOSTATIC PROFILE OF A 3 MONTHS DAILY SUBCUTANEOUS TREATMENT WITH LMW HEPARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 654-654
EFFECT OF SYNTHETIC AND RECOMBINANT INHIBITORS OF THROMBIN ON PLATELET-AGGREGATION - IMPLICATIONS IN THE MANAGEMENT OF VASCULAR AND THROMBOTIC DISORDERS
Authors: KINDEL G FAREED D WALENGA JM BACHER P HOPPENSTEADT D FAREED J
Citation: G. Kindel et al., EFFECT OF SYNTHETIC AND RECOMBINANT INHIBITORS OF THROMBIN ON PLATELET-AGGREGATION - IMPLICATIONS IN THE MANAGEMENT OF VASCULAR AND THROMBOTIC DISORDERS, Thrombosis and haemostasis, 69(6), 1993, pp. 705-705
DOES ANTICOAGULATION WITH HEPARIN FOLLOWED BY DAILY LONG-TERM LMW HEPARIN ACTIVATE THE FIBRINOLYTIC SYSTEM
Authors: BACHER P LOJEWSKI B IQBAL O WALENGA JM LEYA F WOLF H WELZEL D FAREED J
Citation: P. Bacher et al., DOES ANTICOAGULATION WITH HEPARIN FOLLOWED BY DAILY LONG-TERM LMW HEPARIN ACTIVATE THE FIBRINOLYTIC SYSTEM, Thrombosis and haemostasis, 69(6), 1993, pp. 829-829
FIBRINOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SITE-DIRECTED INHIBITORS OF THROMBIN
Authors: CALLAS D BAJUSZ S BACHER P IQBAL O HOPPENSTEADT D FAREED J
Citation: D. Callas et al., FIBRINOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SITE-DIRECTED INHIBITORS OF THROMBIN, Thrombosis and haemostasis, 69(6), 1993, pp. 840-840
OPTIMIZATION OF A DRUG-TREATMENT SCHEDULE FOR POST-PTCA REDUCTION OF RESTENOSIS USING A NONHUMAN PRIMATE MODEL
Authors: WOLF H BACHER P IQBAL O HOPPENSTEADT D WALENGA JM FAREED J
Citation: H. Wolf et al., OPTIMIZATION OF A DRUG-TREATMENT SCHEDULE FOR POST-PTCA REDUCTION OF RESTENOSIS USING A NONHUMAN PRIMATE MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 1028-1028
HEMATOLOGICAL ALTERATIONS DURING A 12 WEEK DAILY ADMINISTRATION OF A LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX(R)) IN PRIMATES
Authors: LOJEWSKI B BACHER P IQBAL O WOLF H FAREED J
Citation: B. Lojewski et al., HEMATOLOGICAL ALTERATIONS DURING A 12 WEEK DAILY ADMINISTRATION OF A LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX(R)) IN PRIMATES, Thrombosis and haemostasis, 69(6), 1993, pp. 1029-1029
MOLECULAR-WEIGHT DEPENDENCE ON THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR AFTER SUBCUTANEOUS AND INTRAVENOUS ACTIONS OF HEPARINS
Authors: LOJEWSKI B BACHER P JESKE W FAREED J
Citation: B. Lojewski et al., MOLECULAR-WEIGHT DEPENDENCE ON THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR AFTER SUBCUTANEOUS AND INTRAVENOUS ACTIONS OF HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1174-1174
PROCOAGULANT AND THROMBOGENIC EFFECTS OF RECOMBINANT TISSUE FACTOR
Authors: CALLAS D BACHER P HOPPENSTEADT D FAREED J
Citation: D. Callas et al., PROCOAGULANT AND THROMBOGENIC EFFECTS OF RECOMBINANT TISSUE FACTOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1175-1175
PLATELET-MEDIATED VASOCONSTRICTION IS NOT SOLELY DEPENDENT UPON THROMBIN - AN EXPERIMENTAL-STUDY WITH R-HIRUDIN AND DEFIBROTIDE
Authors: KINDEL G BACHER P IQBAL O LOJEWSKI B WALENGA JM FAREED J
Citation: G. Kindel et al., PLATELET-MEDIATED VASOCONSTRICTION IS NOT SOLELY DEPENDENT UPON THROMBIN - AN EXPERIMENTAL-STUDY WITH R-HIRUDIN AND DEFIBROTIDE, Thrombosis and haemostasis, 69(6), 1993, pp. 1245-1245
THE THROMBOLYTIC EFFECT OF LMW-HEPARIN DEMONSTRATED IN AN ACUTE SHORT-TERM RABBIT CLOT LYSIS MODEL
Authors: WELZEL D BACHER P IQBAL O HOPPENSTEADT D WALENGA JM FAREED J
Citation: D. Welzel et al., THE THROMBOLYTIC EFFECT OF LMW-HEPARIN DEMONSTRATED IN AN ACUTE SHORT-TERM RABBIT CLOT LYSIS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 1279-1279
STUDIES ON THE MOLECULAR-WEIGHT AND ANTITHROMBIN-III AFFINITY DEPENDENCE OF THE FIBRINOLYTIC ACTIONS OF HEPARINS
Authors: TOULEMONDE F BACHER P HOPPENSTEADT D WALENGA J FAREED J
Citation: F. Toulemonde et al., STUDIES ON THE MOLECULAR-WEIGHT AND ANTITHROMBIN-III AFFINITY DEPENDENCE OF THE FIBRINOLYTIC ACTIONS OF HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1280-1280
EVALUATION OF HEMATOLOGIC ALTERATIONS ASSOCIATED WITH DAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX) FOR A 12-WEEK PERIOD
Authors: LOJEWSKI B BACHER P IQBAL O WALENGA JM HOPPENSTEADT DA LEYA F FAREED J
Citation: B. Lojewski et al., EVALUATION OF HEMATOLOGIC ALTERATIONS ASSOCIATED WITH DAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX) FOR A 12-WEEK PERIOD, Seminars in thrombosis and hemostasis, 19, 1993, pp. 36-43
COMPARATIVE PHARMACOLOGICAL PROFILE OF A GLYCOSAMINOGLYCAN MIXTURE, SULODEXIDE, AND A CHEMICALLY-MODIFIED HEPARIN DERIVATIVE, SULEPAROIDE
Authors: CALLAS DD HOPPENSTEADT DA JESKE W IQBAL O BACHER P AHSAN A FAREED J
Citation: Dd. Callas et al., COMPARATIVE PHARMACOLOGICAL PROFILE OF A GLYCOSAMINOGLYCAN MIXTURE, SULODEXIDE, AND A CHEMICALLY-MODIFIED HEPARIN DERIVATIVE, SULEPAROIDE, Seminars in thrombosis and hemostasis, 19, 1993, pp. 49-57
POSTOPERATIVE MONITORING OF LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS IN HIGH-RISK PATIENTS
Authors: BACHER P HORST B BREYER HG HOPPENSTEADT DA WALENGA JM FAREED J
Citation: P. Bacher et al., POSTOPERATIVE MONITORING OF LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS IN HIGH-RISK PATIENTS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 73-78
A COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF CLEXANE AND LOVENOX IN DOGS
Authors: IQBAL O JESKE W BACHER P HOPPENSTEADT DA WALENGA JM FAREED J
Citation: O. Iqbal et al., A COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF CLEXANE AND LOVENOX IN DOGS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 199-209
MEDICAL AND SURGICAL USES OF RECOMBINANT HIRUDIN - AN INTERNATIONAL DISCUSSION FORUM MUNICH, GERMANY, JUNG 26, 1991
Authors: BACHER P MARKWARDT F MESSMORE H FAREED J WALENGA J HOPPENSTEADT D OFOSU F FINK E AMIRAL J FENTON J SAWYER R MARAGANORE J BREDDIN HK LEYA F HUBBARD T STEMBERGER A KAISER B ROSENKRANZ B KU C BUTTI A PIFARRE R
Citation: P. Bacher et al., MEDICAL AND SURGICAL USES OF RECOMBINANT HIRUDIN - AN INTERNATIONAL DISCUSSION FORUM MUNICH, GERMANY, JUNG 26, 1991, Seminars in thrombosis and hemostasis, 19, 1993, pp. 210-216
REPORT ON THE INTERNATIONAL-SYMPOSIUM ON LOW-MOLECULAR-WEIGHT HEPARINS AND RELATED POLYSACCHARIDES MUNICH, GERMANY, JUNE 27 AND 28, 1991
Authors: HAAS P BREDDIN HK KAKKAR VV VERMYLEN J TENCATE JW BARROWCLIFFE TW HEUCK C HARENBERG J BASICMICIC M BACHER P YIN ET ABILDGARD U SAMAMA M PLANES A ERIKSSON B LEYVRAZ PF BACHER P BERGQVIST D FOBBE F BORRIS L NICOLAIDES A BREYER HG VANDENBROEK MD BERGQVIST D TOULEMONDE F KAKKAR VV WEBER E HARENBERG J HULL RC KIRCHMAIER CM BREDDIN HK VETTERMANN J WENZEL E HAAS S SASAHARA A AMANN FW SUJATTA M CAPRINI JA THOMAS D FAREED J
Citation: P. Haas et al., REPORT ON THE INTERNATIONAL-SYMPOSIUM ON LOW-MOLECULAR-WEIGHT HEPARINS AND RELATED POLYSACCHARIDES MUNICH, GERMANY, JUNE 27 AND 28, 1991, Seminars in thrombosis and hemostasis, 19, 1993, pp. 217-226
THE ANTITHROMBOTIC AND ANTICOAGULANT EFFECTS OF A SYNTHETIC TRIPEPTIDE AND RECOMBINANT HIRUDIN IN VARIOUS ANIMAL-MODELS
Authors: BACHER P WALENGA JM IQBAL O BAJUSZ S BREDDIN K FAREED J
Citation: P. Bacher et al., THE ANTITHROMBOTIC AND ANTICOAGULANT EFFECTS OF A SYNTHETIC TRIPEPTIDE AND RECOMBINANT HIRUDIN IN VARIOUS ANIMAL-MODELS, Thrombosis research, 71(4), 1993, pp. 251-263
Risultati: 1-25 | 26-28